Lexeo Therapeutics Target Price

Explore Lexeo Therapeutics's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.89

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-01-13	H.C. WainwrightMitchell Kapoor	$10	104.5% upside
2025-12-17	Raymond James	$25	411.2% upside
2025-12-10	OppenheimerLeland Gershell	$20	309% upside
2025-11-20	Cantor Fitzgerald	$19	288.5% upside
2025-10-21	H.C. Wainwright	$13	165.8% upside
2025-10-15	Guggenheim	$30	513.5% upside
2025-10-07	Chardan Capital	$17	247.6% upside
2025-10-07	H.C. Wainwright	$15	206.7% upside
2025-10-07	Leerink PartnersMani Foroohar	$20	309% upside
2024-06-12	Robert W. BairdBrian Skorney	$28	472.6% upside

Lexeo Therapeutics (LXEO) FAQ

Stockcircle tracks target price for Lexeo Therapeutics (LXEO), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Lexeo Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main LXEO overview so you can move from this figure to the surrounding analysis quickly.